Published • loading... • Updated
Finland’s Grundium acquires Denmark’s Visiopharm to build an end-to-end AI precision pathology platform
Summary by EU-Startups
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Finland’s Grundium acquires Denmark’s Visiopharm to build an end-to-end AI precision pathology platform
Grundium, a Tampere-based startup specialising in digital pathology imaging technology, backed by US-based healthcare private equity firm EW Healthcare Partners, has acquired Visiopharm, a Denmark-based provider of AI-driven precision pathology software. The combined business merges complementary capabilities from Grundium’s imaging platform and Visiopharm’s AI-driven precision pathology software, creating an accessible end-to-end solution for d…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
